Latin America Sepsis Diagnostics Market: By Product (Instruments, Blood Culture Media, Assay Kits and Reagents, Software), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), By Pathogen Type (Bacterial Sepsis [Gram-Positive Bacteria and Gram-Negative Bacteria], Fungal Sepsis, and Others), By Test Type (Laboratory Tests and Point-Of-Care Tests) and Country

The Latin America Sepsis Diagnostics Market size is valued at USD 180.9 million in 2021 and is expected to grow at a significant CAGR of 7.5% during the forecast period from 2022 to 2028. The market provides a detailed overview of the market and that can be segmented By Product, Technology, Pathogen, Testing Type. By Product, the market has been segmented into Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry. The Microbiology segment is likely to be the largest and fastest-growing segment in terms of Product. Based on pathogen type, the Latin America sepsis diagnostics market is segmented into Bacterial Sepsis, Fungal Sepsis, and Others.  Among these, the bacterial sepsis segment is expected to have the fastest-growing market during the forecast period 2022-2028. By Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Conventional Diagnostics are expected to dominate the market in the future. Based on test type, the market has been segmented into Laboratory Tests and Point-Of-Care Tests. Laboratory Tests segment expected to grow at the highest CAGR over the forecast years. Based on the end-user, the market has been segregated into Hospitals, Pathology & Reference Laboratories. The Hospitals segment is to dominate other segments in the Latin America Sepsis Diagnostics market according to Precision Business Insights. Key Development: In January 2020, Roche and Inotrem SA, a France-based company, formed a strategic agreement for the commercialization of a companion diagnostics test intended for septic shock.